{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:14:51Z","timestamp":1761178491300,"version":"build-2065373602"},"reference-count":36,"publisher":"Elsevier BV","issue":"6-7","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer\/Radioth\u00e9rapie"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.canrad.2016.07.096","type":"journal-article","created":{"date-parts":[[2016,9,9]],"date-time":"2016-09-09T19:13:59Z","timestamp":1473448439000},"page":"645-650","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["D\u00e9termination des marges du volume cible anatomoclinique au volume cible pr\u00e9visionnel pour la radioth\u00e9rapie des cancers du canal anal"],"prefix":"10.1016","volume":"20","author":[{"given":"V.","family":"Libois","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.-A.","family":"Mah\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Rio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Maingon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.canrad.2016.07.096_bib0360","first-page":"269","article-title":"Anatomie pathologique des cancers du canal anal","volume":"3","author":"Fl\u00e9jou","year":"2011","journal-title":"Canc\u00e9ro Dig"},{"key":"10.1016\/j.canrad.2016.07.096_bib0190","doi-asserted-by":"crossref","first-page":"iii10","DOI":"10.1093\/annonc\/mdu159","article-title":"Anal cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"25","author":"Glynne-Jones","year":"2014","journal-title":"Ann Oncol"},{"key":"10.1016\/j.canrad.2016.07.096_bib0195","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1056\/NEJMoa1010971","article-title":"HPV vaccine against anal HPV infection and anal intraepithelial neoplasia","volume":"365","author":"Palefsky","year":"2011","journal-title":"N Engl J Med"},{"year":"2009","series-title":"International Union Against Cancer (UICC). TNM classification of malignant tumours","author":"Sobin","key":"10.1016\/j.canrad.2016.07.096_bib0200"},{"key":"10.1016\/j.canrad.2016.07.096_bib0205","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S1470-2045(13)70086-X","article-title":"Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2\u00d72 factorial trial","volume":"14","author":"James","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canrad.2016.07.096_bib0210","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1200\/JCO.2011.35.4837","article-title":"Induction chemotherapy and dose intensification of the radiation boost in locally advanced anal canal carcinoma: final analysis of the randomized UNICANCER ACCORD 03\u00a0trial","volume":"30","author":"Peiffert","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2016.07.096_bib0215","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0360-3016(97)85445-4","article-title":"Radiotherapy with concomitant chemotherapy superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the EORTC radiotherapy and gastrointestinal tract cooperative groups","volume":"36","author":"Bartelink","year":"1996","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2016.07.096_bib0220","doi-asserted-by":"crossref","first-page":"4344","DOI":"10.1200\/JCO.2012.43.8085","article-title":"Long-term update of US GI intergroup RTOG 98-11\u00a0phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil\/mitomycin versus fluorouracil\/cisplatin","volume":"30","author":"Gunderson","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2016.07.096_bib0225","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0140-6736(96)03409-5","article-title":"Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin","volume":"348","author":"Party","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.canrad.2016.07.096_bib0230","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1001\/jama.299.16.1914","article-title":"Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial","volume":"299","author":"Ajani","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.canrad.2016.07.096_bib0235","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1038\/bjc.2014.467","article-title":"Chemoradiotherapy with capecitabine for locally advanced anal carcinoma: an alternative treatment option","volume":"111","author":"Meulendijks","year":"2014","journal-title":"Br J Cancer"},{"key":"10.1016\/j.canrad.2016.07.096_bib0240","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.radonc.2015.07.050","article-title":"Evaluation of a 36Gy elective node irradiation dose in anal cancer","volume":"116","author":"L\u00e9pinoy","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2016.07.096_bib0245","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/S0360-3016(03)00417-6","article-title":"Results of definitive irradiation in a series of 305\u00a0epidermoid carcinomas of the anal canal","volume":"56","author":"Deniaud-Alexandre","year":"2003","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.canrad.2016.07.096_bib0250","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0360-3016(01)01510-3","article-title":"The impact of gap duration on local control in anal canal carcinoma treated by split-course radiotherapy and concomitant chemotherapy","volume":"50","author":"Weber","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2016.07.096_bib0255","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1684\/bdc.2010.1148","article-title":"Radioth\u00e9rapie conformationnelle par modulation d\u2019intensit\u00e9","volume":"97","author":"Maingon","year":"2010","journal-title":"Bull Cancer (Paris)"},{"key":"10.1016\/j.canrad.2016.07.096_bib0260","doi-asserted-by":"crossref","first-page":"e201","DOI":"10.1016\/j.ijrobp.2012.12.008","article-title":"Simultaneous integrated boost\u2013intensity modulated radiation therapy with concomitant capecitabine and mitomycin c for locally advanced anal carcinoma: a phase 1\u00a0study","volume":"85","author":"Deenen","year":"2013","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.canrad.2016.07.096_bib0265","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0360-3016(99)00101-7","article-title":"Smart (simultaneous modulated accelerated radiation therapy) boost: a new accelerated fractionation schedule for the treatment of head and neck cancer with intensity modulated radiotherapy","volume":"45","author":"Butler","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2016.07.096_bib0270","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.canrad.2014.12.005","article-title":"Place de l\u2019arcth\u00e9rapie modul\u00e9e et de la chimioth\u00e9rapie concomitante dans la prise en charge des cancers du canal anal localement \u00e9volu\u00e9s","volume":"19","author":"Troussier","year":"2015","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2016.07.096_bib0275","series-title":"Site Internet de radioanatomie et d\u2019autoenseignement \u00e0 la delineation (Siriade)","article-title":"RCMI canal","author":"Azria","year":"2011"},{"key":"10.1016\/j.canrad.2016.07.096_bib0280","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.ijrobp.2008.08.070","article-title":"Elective clinical target volumes for conformal therapy in anorectal cancer: a radiation therapy oncology group consensus panel contouring atlas","volume":"74","author":"Myerson","year":"2009","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.canrad.2016.07.096_bib0285","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/j.ijrobp.2011.12.058","article-title":"Australasian gastrointestinal trials group (AGITG) contouring atlas and planning guidelines for intensity-modulated radiotherapy in anal cancer","volume":"83","author":"Ng","year":"2012","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.canrad.2016.07.096_bib0290","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.canrad.2013.06.032","article-title":"Recommandations pour la d\u00e9lin\u00e9ation des aires ganglionnaires pelviennes dans le cancer du canal anal","volume":"17","author":"Vendrely","year":"2013","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2016.07.096_bib0365","first-page":"414","article-title":"Toxicity of treatment for anal carcinoma: 2D versus 3D planning","volume":"17","author":"Atrash","year":"2015","journal-title":"Isr Med Assoc J IMAJ"},{"key":"10.1016\/j.canrad.2016.07.096_bib0300","first-page":"39","article-title":"Intensity-modulated radiation therapy vs 3D conformal radiation therapy for squamous cell carcinoma of the anal canal","volume":"6","author":"Chuong","year":"2013","journal-title":"Gastrointest Cancer Res"},{"key":"10.1016\/j.canrad.2016.07.096_bib0305","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.radonc.2008.04.011","article-title":"The effect of intensity-modulated radiotherapy and high dose rate brachytherapy on acute and late radiotherapy-related adverse events following chemoradiotherapy of anal cancer","volume":"87","author":"Saarilahti","year":"2008","journal-title":"Radiother Oncol"},{"author":"HAS","key":"10.1016\/j.canrad.2016.07.096_bib0310"},{"key":"10.1016\/j.canrad.2016.07.096_bib0315","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.canrad.2014.07.017","article-title":"\u00c9valuation de la toxicit\u00e9 aigu\u00eb de la tomoth\u00e9rapie et de l\u2019arcth\u00e9rapie volum\u00e9trique modul\u00e9e pour les cancers pelviens\u00a0: premiers r\u00e9sultats de l\u2019\u00e9tude \u00ab\u00a0Artpelvis\u00a0\u00bb","volume":"18","author":"Mah\u00e9","year":"2014","journal-title":"Cancer Radiother"},{"issue":"1","key":"10.1016\/j.canrad.2016.07.096_bib0370","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ijrobp.2012.09.023","article-title":"RTOG 0529: a phase 2 evaluation of dose-painted intensity modulated radiation therapy in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in carcinoma of the anal canal","volume":"86","author":"Kachnic","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2016.07.096_bib0325","doi-asserted-by":"crossref","first-page":"S120","DOI":"10.1016\/S1278-3218(10)70015-9","article-title":"Cancer du canal anal","volume":"14","author":"Fesneau","year":"2010","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2016.07.096_bib0330","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0167-8140(02)00140-8","article-title":"Geometrical uncertainties, radiotherapy planning margins, and the ICRU-62\u00a0report","volume":"64","author":"Stroom","year":"2002","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2016.07.096_bib0335","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ijrobp.2011.10.068","article-title":"Setup variations in radiotherapy of anal cancer: advantages of target volume reduction using image-guided radiation treatment","volume":"84","author":"Chen","year":"2012","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.canrad.2016.07.096_bib0340","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.radonc.2012.04.005","article-title":"Large prostate motion produced by anal contraction","volume":"104","author":"Onishi","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2016.07.096_bib0345","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.clon.2011.07.012","article-title":"Image-guided radiotherapy for rectal cancer\u00a0\u2013\u00a0a systematic review","volume":"24","author":"Gwynne","year":"2012","journal-title":"Clin Oncol"},{"key":"10.1016\/j.canrad.2016.07.096_bib0350","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.ijrobp.2008.02.032","article-title":"Assessment of intrafractional movement and internal motion in radiotherapy of rectal cancer using megavoltage computed tomography","volume":"71","author":"Tournel","year":"2008","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.canrad.2016.07.096_bib0355","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1080\/02841860802256459","article-title":"IGRT in rectal cancer","volume":"47","author":"Ippolito","year":"2008","journal-title":"Acta Oncol"},{"key":"10.1016\/j.canrad.2016.07.096_bib0180","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.radonc.2011.05.076","article-title":"Bowel exposure in rectal cancer IMRT using prone, supine, or a belly board","volume":"102","author":"Nijkamp","year":"2012","journal-title":"Radiother Oncol"}],"container-title":["Cancer\/Radioth\u00e9rapie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321816303754?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321816303754?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T12:27:13Z","timestamp":1761136033000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1278321816303754"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":36,"journal-issue":{"issue":"6-7","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S1278321816303754"],"URL":"https:\/\/doi.org\/10.1016\/j.canrad.2016.07.096","relation":{},"ISSN":["1278-3218"],"issn-type":[{"type":"print","value":"1278-3218"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"D\u00e9termination des marges du volume cible anatomoclinique au volume cible pr\u00e9visionnel pour la radioth\u00e9rapie des cancers du canal anal","name":"articletitle","label":"Article Title"},{"value":"Cancer\/Radioth\u00e9rapie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canrad.2016.07.096","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Soci\u00e9t\u00e9 fran\u00e7aise de radioth\u00e9rapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}